SAROJASpecialty Chemicals
Saroja Pharma Indus Ind L — Balance Sheet
₹28.00
+0.00%
Saroja Pharma Indus Ind L Balance Sheet (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Net Debt | 5.41 Cr | 9.82 Cr | 5.87 Cr | 3.01 Cr |
| Total Debt | 5.74 Cr | 10.19 Cr | 6.14 Cr | 3.02 Cr |
| Tangible Book Value | 14.64 Cr | 5.09 Cr | 4.02 Cr | 0.93 Cr |
| Invested Capital | 20.38 Cr | 15.28 Cr | 10.16 Cr | 3.95 Cr |
| Working Capital | 8.31 Cr | 2.72 Cr | 5.31 Cr | 2.23 Cr |
| Net Tangible Assets | 14.64 Cr | 5.09 Cr | 4.02 Cr | 0.93 Cr |
| Common Stock Equity | 14.64 Cr | 5.09 Cr | 4.03 Cr | 0.94 Cr |
| Total Capitalization | 17.26 Cr | 7.90 Cr | 5.72 Cr | 2.35 Cr |
| Total Equity Gross Minority Interest | 14.64 Cr | 5.09 Cr | 4.03 Cr | 0.94 Cr |
| Stockholders Equity | 14.64 Cr | 5.09 Cr | 4.03 Cr | 0.94 Cr |
| Retained Earnings | 3.03 Cr | 2.15 Cr | 2.07 Cr | 0.93 Cr |
| Additional Paid In Capital | 7.59 Cr | 0.00 | 1.73 Cr | 0.00 |
| Capital Stock | 4.02 Cr | 2.94 Cr | 0.23 Cr | 0.01 Cr |
| Common Stock | 4.02 Cr | 2.94 Cr | 0.23 Cr | 0.01 Cr |
| Total Liabilities Net Minority Interest | 11.92 Cr | 16.25 Cr | 11.49 Cr | 7.29 Cr |
| Total Non Current Liabilities Net Minority Interest | 2.63 Cr | 2.82 Cr | 1.70 Cr | 1.42 Cr |
| Other Non Current Liabilities | -1000.00 | — | — | 1000.00 |
| Non Current Deferred Taxes Liabilities | 85000.00 | 0.01 Cr | 34000.00 | 18000.00 |
| Long Term Debt And Capital Lease Obligation | 2.62 Cr | 2.81 Cr | 1.70 Cr | 1.42 Cr |
| Long Term Debt | 2.62 Cr | 2.81 Cr | 1.70 Cr | 1.42 Cr |
| Current Liabilities | 9.29 Cr | 13.43 Cr | 9.79 Cr | 5.87 Cr |
| Other Current Liabilities | 0.51 Cr | — | — | — |
| Current Deferred Taxes Liabilities | 38000.00 | 0.17 Cr | 0.00 | 0.08 Cr |
| Current Debt And Capital Lease Obligation | 3.11 Cr | 7.38 Cr | 4.44 Cr | 1.60 Cr |
| Current Debt | 3.11 Cr | 7.38 Cr | 4.44 Cr | 1.60 Cr |
| Payables | 5.66 Cr | 5.88 Cr | 5.33 Cr | 4.18 Cr |
| Other Payable | 0.01 Cr | 47000.00 | 0.02 Cr | 0.03 Cr |
| Total Tax Payable | 0.04 Cr | 0.01 Cr | — | — |
| Accounts Payable | 5.61 Cr | 5.86 Cr | 5.31 Cr | 4.15 Cr |
| Total Assets | 26.56 Cr | 21.34 Cr | 15.51 Cr | 8.22 Cr |
| Total Non Current Assets | 8.96 Cr | 5.19 Cr | 0.42 Cr | 0.12 Cr |
| Non Current Prepaid Assets | 0.13 Cr | 1.04 Cr | 0.04 Cr | 0.03 Cr |
| Other Investments | 0.20 Cr | 0.14 Cr | 0.04 Cr | 25000.00 |
| Goodwill And Other Intangible Assets | 0.00 | 14000.00 | 26000.00 | 44000.00 |
| Net PPE | 8.64 Cr | 4.00 Cr | 0.34 Cr | 0.08 Cr |
| Accumulated Depreciation | -0.23 Cr | -0.13 Cr | -0.07 Cr | -0.03 Cr |
| Gross PPE | 8.86 Cr | 4.14 Cr | 0.41 Cr | 0.11 Cr |
| Construction In Progress | 6.13 Cr | 1.79 Cr | 0.00 | 0.00 |
| Other Properties | 0.16 Cr | 0.11 Cr | 0.08 Cr | 0.04 Cr |
| Machinery Furniture Equipment | 0.68 Cr | 0.34 Cr | 0.33 Cr | 0.07 Cr |
| Land And Improvements | 1.90 Cr | 1.90 Cr | 0.00 | — |
| Properties | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 17.60 Cr | 16.15 Cr | 15.09 Cr | 8.10 Cr |
| Prepaid Assets | 0.06 Cr | 0.08 Cr | 0.29 Cr | 0.07 Cr |
| Inventory | 0.40 Cr | 3.87 Cr | 0.47 Cr | 0.66 Cr |
| Finished Goods | 0.40 Cr | 3.87 Cr | 0.47 Cr | 0.66 Cr |
| Other Receivables | 70000.00 | 8000.00 | 0.01 Cr | 94000.00 |
| Taxes Receivable | 0.57 Cr | 0.55 Cr | 0.07 Cr | 0.14 Cr |
| Accounts Receivable | 16.24 Cr | 11.11 Cr | 13.98 Cr | 7.22 Cr |
| Cash Cash Equivalents And Short Term Investments | 0.32 Cr | 0.36 Cr | 0.26 Cr | 41000.00 |
| Cash And Cash Equivalents | 0.32 Cr | 0.36 Cr | 0.26 Cr | 41000.00 |
| Cash Equivalents | 0.28 Cr | 0.34 Cr | 0.26 Cr | 10000.00 |
| Cash Financial | 0.05 Cr | 0.02 Cr | 52000.00 | 31000.00 |
| Ordinary Shares Number | — | 0.40 Cr | 0.40 Cr | 0.40 Cr |
| Share Issued | — | 0.40 Cr | 0.40 Cr | 0.40 Cr |
| Non Current Deferred Taxes Assets | — | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | — | 14000.00 | 26000.00 | 44000.00 |
| Other Current Assets | — | 0.18 Cr | 0.01 Cr | — |
| Raw Materials | — | 0.00 | 0.00 | 0.00 |
| Current Provisions | — | — | 0.01 Cr | 0.02 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Saroja Pharma Indus Ind L
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.